Nutex Health, Inc. financial data

Symbol
NUTX on Nasdaq
Industry
Services-Business Services, NEC
Location
6030 S. Rice Ave., Suite C, Houston, TX
State of incorporation
DE
Fiscal year end
December 31
Former names
Clinigence Holdings, Inc. (to 3/31/2022), iGambit, Inc. (to 11/13/2019)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 165 % +1.86%
Quick Ratio 4.42 % -17.2%
Debt-to-equity 542 % +50.7%
Return On Equity -51.3 % -96.3%
Return On Assets -9.89 % -51.9%
Operating Margin -3.33 % +32.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.44M shares -99.2%
Common Stock, Shares, Outstanding 5.22M shares +16.6%
Entity Public Float 145M USD -86%
Common Stock, Value, Issued 5.22K USD +16.6%
Weighted Average Number of Shares Outstanding, Basic 5.1M shares +15%
Weighted Average Number of Shares Outstanding, Diluted 4.43M shares -99.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 292M USD +26%
Revenue from Contract with Customer, Excluding Assessed Tax 29M USD
Cost of Revenue 17.6M USD +664%
Research and Development Expense 283K USD -45.5%
General and Administrative Expense 37.7M USD +21.4%
Costs and Expenses 224M USD +5.01%
Operating Income (Loss) -9.73M USD +14.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -29.5M USD -10.9%
Income Tax Expense (Benefit) 2.87M USD
Net Income (Loss) Attributable to Parent -41.1M USD -42.2%
Earnings Per Share, Basic -1.85 USD/shares +15.1%
Earnings Per Share, Diluted -1.85 USD/shares +15.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 46.9M USD +74.9%
Accounts Receivable, after Allowance for Credit Loss, Current 62.7M USD +17.9%
Inventory, Net 2.26M USD -15.8%
Assets, Current 120M USD +33.3%
Property, Plant and Equipment, Net 14.8K USD +30.5%
Operating Lease, Right-of-Use Asset 11.4M USD -31.5%
Intangible Assets, Net (Excluding Goodwill) 15.9M USD -26.7%
Goodwill 13.9M USD -22.4%
Assets 438M USD -8.58%
Accounts Payable, Current 10.3M USD -41.4%
Accrued Liabilities, Current 157K USD -22.3%
Liabilities, Current 67.6M USD +0.43%
Deferred Income Tax Liabilities, Net 3.4M USD -59.9%
Operating Lease, Liability, Noncurrent 14.3M USD -9.87%
Liabilities 359M USD -4.28%
Retained Earnings (Accumulated Deficit) -419M USD -10.9%
Stockholders' Equity Attributable to Parent 60.4M USD -32.8%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 79.8M USD -24%
Liabilities and Equity 438M USD -8.58%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 3.05M USD +190%
Net Cash Provided by (Used in) Financing Activities 5.69M USD +93.1%
Net Cash Provided by (Used in) Investing Activities -733K USD +86.5%
Common Stock, Shares Authorized 950M shares 0%
Common Stock, Shares, Issued 5.22M shares -99.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 36.6M USD +6.96%
Interest Paid, Excluding Capitalized Interest, Operating Activities 548K USD +27.3%
Deferred Tax Assets, Valuation Allowance 7.48M USD
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 1.78 pure +2443%
Deferred Tax Assets, Gross 19.5M USD +117%
Operating Lease, Liability 91.2K USD
Depreciation 1.56K USD +48.4%
Payments to Acquire Property, Plant, and Equipment 3.07M USD +38131%
Property, Plant and Equipment, Gross 102M USD +0%
Operating Lease, Liability, Current 2.06M USD +31.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +25%
Deferred Income Tax Expense (Benefit) -95.4K USD +89.5%
Deferred Tax Assets, Operating Loss Carryforwards 3.81M USD +123%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100M shares 0%
Operating Lease, Payments 12.9K USD
Additional Paid in Capital 479M USD +2.49%
Preferred Stock, Shares Outstanding 0 shares
Operating Leases, Future Minimum Payments, Due in Two Years 53.4K USD
Amortization of Intangible Assets 1.5M USD -6.25%
Depreciation, Depletion and Amortization 4.19M USD +4.82%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 38.9K USD
Deferred Tax Assets, Net of Valuation Allowance 2.4M USD
Operating Leases, Future Minimum Payments, Due in Three Years 4.46K USD
Operating Leases, Future Minimum Payments Due 96.8K USD
Interest Expense 17.6M USD +27.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%